Form 4 holding
Chief Executive Officer, Director
LEXICON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 1,098,068
- Estimated value
- $2,876,938
- Report date
- 28 Feb 2024
- Price
- $2.62
- Ownership
- Direct
Lonnel Coats - Chief Executive Officer, Director at LEXICON PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- LXRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Lonnel Coats since 13 Sep 2025
Reported holdings for Lonnel Coats in LEXICON PHARMACEUTICALS, INC.
Form 4 holding
Chief Executive Officer, Director
LEXICON PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Units
- Shares / value
- 240,767
- Estimated value
- $630,810
- Report date
- 28 Feb 2024
- Price
- $2.62
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
LEXICON PHARMACEUTICALS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 770,420
- Estimated value
- Report date
- 08 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Lonnel Coats in LEXICON PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.